Fact check
“The FDA is contemplating reforms to add more flexibility for companies to get more products authorized.”
Reasoning
The supplied evidence quotes the article: "The FDA is now contemplating reforms aimed at addressing the problems described in the lawsuit. 'The agency is looking to add more flexibility for companies to get more..." This directly confirms the claim.
On confidence: Two independent excerpts from the same Reason.com article directly state that the FDA is contemplating reforms to add more flexibility for companies to get more products authorized.
Important context
The statement refers specifically to reforms related to nicotine product approvals, as discussed in the Reason.com article dated September 30, 2026.
Evidence
Supporting (2)
- Tier 1 — Primary sourceThe FDA promises to streamline the dauntingly complex rules for approving nicotine products
and exacerbated." Last May, the FDA "again recognized the statutory and other problems with the backlog of applications" by issuing "guidance for de-prioritizing enforcement action against products in certain categories," the lawsuit says.…
- Tier 1 — Primary sourceThe FDA promises to streamline the dauntingly complex rules for approving nicotine products
products authorized," the Journal reports. "One potential way to do that is by simplifying requirements for scientific studies and speeding review times….The administration hopes to see products it considers less harmful for smokers, such…
Limitations
Both pieces of evidence come from the same source (Reason.com). No additional independent sources are provided to corroborate the claim beyond this article. No independent origin corroborated this claim, so it cannot be verified and confidence cannot be high.
- Last verified:
- Oct 1, 2026, 4:41 AM CDT
- Pipeline:
- 2.1.0
- Claim type:
- Factual
Where this claim appeared
The FDA Promises To Streamline the Dauntingly Complex Rules for Approving Nicotine ProductsReason · Jacob Sullum